Merit Medical Systems, Inc. (NASDAQ:MMSI - Get Free Report) has been assigned an average rating of "Moderate Buy" from the thirteen research firms that are presently covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $105.55.
A number of equities analysts have recently commented on MMSI shares. Raymond James Financial reissued an "outperform" rating and issued a $100.00 price target on shares of Merit Medical Systems in a report on Friday, July 31st. JPMorgan Chase & Co. increased their target price on Merit Medical Systems from $95.00 to $110.00 and gave the company an "overweight" rating in a research note on Friday, October 30th. Barrington Research set a $114.00 price target on Merit Medical Systems in a research report on Friday, July 31st. Piper Sandler lifted their price target on Merit Medical Systems from $96.00 to $106.00 and gave the stock an "overweight" rating in a research note on Friday, July 31st. Finally, Needham & Company LLC lifted their price target on Merit Medical Systems from $101.00 to $106.00 and gave the stock a "buy" rating in a research note on Friday, October 30th.
Read Our Latest Stock Analysis on Merit Medical Systems
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of MMSI. Jump Financial LLC raised its stake in shares of Merit Medical Systems by 25.9% during the third quarter. Jump Financial LLC now owns 52,591 shares of the medical instruments supplier's stock worth $4,535,000 after acquiring an additional 10,825 shares in the last quarter. Empowered Funds LLC boosted its stake in shares of Merit Medical Systems by 2.5% in the 3rd quarter. Empowered Funds LLC now owns 4,808 shares of the medical instruments supplier's stock valued at $415,000 after purchasing an additional 118 shares in the last quarter. Benjamin Edwards Inc. boosted its stake in shares of Merit Medical Systems by 12.2% in the 3rd quarter. Benjamin Edwards Inc. now owns 12,070 shares of the medical instruments supplier's stock valued at $1,041,000 after purchasing an additional 1,309 shares in the last quarter. First Trust Advisors LP boosted its stake in shares of Merit Medical Systems by 13.0% in the 3rd quarter. First Trust Advisors LP now owns 25,397 shares of the medical instruments supplier's stock valued at $2,190,000 after purchasing an additional 2,912 shares in the last quarter. Finally, Ieq Capital LLC raised its position in Merit Medical Systems by 13.0% in the 3rd quarter. Ieq Capital LLC now owns 20,784 shares of the medical instruments supplier's stock worth $1,792,000 after purchasing an additional 2,398 shares during the period. 99.66% of the stock is currently owned by institutional investors.
Merit Medical Systems Stock Performance
NASDAQ MMSI opened at $86.63 on Monday. Merit Medical Systems has a 1 year low of $59.74 and a 1 year high of $94.85. The company has a debt-to-equity ratio of 0.42, a current ratio of 4.52 and a quick ratio of 3.05. The stock has a market capitalization of $5.19 billion, a PE ratio of 32.57, a P/E/G ratio of 2.11 and a beta of 0.56. The company's 50 day simple moving average is $88.02 and its two-hundred day simple moving average is $77.40.
Merit Medical Systems (NASDAQ:MMSI - Get Free Report) last released its quarterly earnings results on Thursday, October 29th. The medical instruments supplier reported $1.12 EPS for the quarter, beating analysts' consensus estimates of $1.04 by $0.08. The firm had revenue of $416.24 million during the quarter, compared to analyst estimates of $410.56 million. Merit Medical Systems had a net margin of 9.94% and a return on equity of 14.12%. The business's revenue for the quarter was up 8.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.92 EPS. Analysts predict that Merit Medical Systems will post 3.86 earnings per share for the current fiscal year.
About Merit Medical Systems
(
Get Free Report)
Merit Medical Systems develops, manufactures and markets medical devices used in diagnostic and interventional procedures. Its products support clinicians in areas including cardiology, radiology, oncology and endoscopy. The company's portfolio includes devices and accessories for vascular access, diagnostic and therapeutic procedures, drainage, biopsy and embolization. Merit serves hospitals, clinics and other healthcare providers through direct sales and distribution channels. Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves customers in the United States and internationally.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Merit Medical Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merit Medical Systems wasn't on the list.
While Merit Medical Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.